The chemical constituents

efficacy

in vivo process and related intellectual property rights on Abelmoschi Corolla were summarized. The main chemical structure types from Abelmoschi Corolla include myricetin

quercetin and gossypetin. It was mainly used for chronic kidney disease and wound infection

with the ability to suppress the immune response and anti-inflammatory effect. The metabolic processes in vivo involved in carboxyl reaction

acetylation reaction

hydrolysis reaction

and absorption by passive diffusion. Intellectual property rights concentrated on compund extraction

preparation and drug compatibility

lacking modern clinical and basic research.This paper reviewed progress on Abelmoschi Corollat

put forward the research idea.